Skip to main content
ES
v1.2
Log in
M

Mankind Pharma

MANKIND PHARMANSE
₹2,535+0.00 (+0.00%)
Market Cap
₹93,730Cr.
P/E Ratio
44.0
P/B Ratio
6.42
EPS (TTM)
₹57.61
Div Yield
0.04%
ROCE
13.5%
ROE
13.1%
52W Low: ₹1,91052W High: ₹2,642
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 18.0% a year over three years.
  • Debt is 0.39× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Mankind_Pharma — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
5/ 10Overall
3/ 10Valuation
6/ 10Quality
4/ 10Fundamental
7/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 44.0P/E: 44.0 | P/B: 6.42
Growth
GrowingSales CAGR — 3Y: 18% · 1Y: 14%
Profitability
ModerateROCE: 13.5% | ROE: 13.1%

Key Metrics

Valuation
PEG Ratio 2.59
Price / Sales 6.36x
Price / FCF 39.3x
Book Value ₹395
Margins & returns
Operating Margin 26%
Net Margin 14.0%
Return on Assets 7.5%

Frequently Asked Questions

MarketsPortfolioChart